Karakurt F, Kargili A, Kasapoglu B.
Endocrinology Department, Fatih University Hospital, 06510 Ankara Turkey.
Pioglitazone is used to improve insulin sensitivity in type 2 diabetes. This group of drugs is usually well tolerated; however, their use may be associated with several adverse effects including edema, weight gain, macular edema and heart failure. Herein we report a patient who developed pancytopenia on the 7th day of oral pioglitazone treatment for the control of diabetes mellitus and fully recovered 6 days after the cessation of this drug. To the best of our knowledge this is the first reported case of pancytopenia induced by pioglitazone therapy. J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart. New York.
PMID: 19834871
| < Prev | Next > |
|---|
